MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
PATH EX, Inc.
PATH EX, Inc.

PATH EX has developed a proprietary technology to selectively separate and capture bacteria and endotoxin from human blood, for the diagnosis and treatment of sepsis and bacteremia. The PATH EX technology can separate and capture bacteria and endotoxin regardless of bacteria type or drug-resistance and has shown a capture efficiency greater than 99%. The PATH EX device can treat an entire septic patient in less than 1 hour, and can diagnose infection directly from a blod sample.
PATH EX is focused on the rapid diagnosis and treatment of sepsis through a unique pathogen extraction platform.

Connect with PATH EX, Inc.

2020

2020 Diamond Texas Houston

Sub industry

Medical Devices

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.